ScholarLens Back to search
2018•JAMA Internal MedicineOpen access

Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration

Pieter A. Cohen, Anita Wen, Roy R. L. Gerona

Open full text 32 citations

Abstract

This analysis of dietary supplements purchased in 2014 and purchased again in 2017 examines whether stimulants that were initially present were still present after issuance of public notices by the US Food and Drug Administration to remove potentially hazardous ingredients.

Open-access reader

About this research paper

What this paper is about

This analysis of dietary supplements purchased in 2014 and purchased again in 2017 examines whether stimulants that were initially present were still present after issuance of public notices by the US Food and Drug Administration to remove potentially hazardous ingredients.

Why it matters

OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This analysis of dietary supplements purchased in 2014 and purchased again in 2017 examines whether stimulants that were initially present were still present after issuance of public notices by the US Food and Drug Administration to remove potentially hazardous ingredients.

Key concepts: Medicine, Food and drug administration, Drug, Dietary supplement, Administration (probate law), Drug administration, Action (physics), Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug Administration — Research Paper | ScholarLens